Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DM5C86M)

Drug Name

ISIS 9069 Drug Info

Indication

Disease Entry	ICD 11	Status	REF
Discovery agent	N.A.	Investigative	[1]

Cross-matching ID

Molecule-Related Drug Atlas

Molecule Type:

DTT

Drug Status:

Clinical Trial Drug(s)

Investigative Drug(s)

Download the Complete Related Drug List

Drug(s) Targeting A-Raf messenger RNA (ARAF mRNA)

Drug Name	Drug ID	Indication	ICD 11	Highest Status	REF
RG7304	DMGFAVQ	Solid tumour/cancer	2A00-2F9Z	Phase 1	[2]
ISIS 9065	DMH50RX	Discovery agent	N.A.	Investigative	[1]
ISIS 9063	DM8E5RO	Discovery agent	N.A.	Investigative	[1]
ISIS 10228	DMESKQX	Discovery agent	N.A.	Investigative	[3]
ISIS 9064	DMBMTGP	Discovery agent	N.A.	Investigative	[1]
ISIS 9061	DMFAL2E	Discovery agent	N.A.	Investigative	[1]
ISIS 9071	DMWY2XB	Discovery agent	N.A.	Investigative	[1]
ISIS 9060	DMZL7SW	Discovery agent	N.A.	Investigative	[1]
ISIS 9070	DMU0HQF	Discovery agent	N.A.	Investigative	[1]
ISIS 9067	DML8HCZ	Discovery agent	N.A.	Investigative	[1]
------------------------------------------------------------------------------------


⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas

Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)

References

1	US patent application no. 5,563,255, Antisense oligonucleotide modulation of raf gene expression.
2	Clinical pipeline report, company report or official report of Roche.
3	US patent application no. 5,952,229, Antisense oligonucleotide modulation of raf gene expression.